Skip to content

Exponent EXPO Accounts Receivable

Accounts Receivable at other companies

Jacobs Solutions logo
Jacobs SolutionsJ
$3.56B+22.8%
FTI Consulting logo
FTI ConsultingFCN
$823.86M+7.9%
Amentum Holdings logo
Amentum HoldingsAMTM
$2.5B-0.5%
TIC Solutions
 logo
TIC Solutions TIC
$526.98M+198%
Element Solutions logo
Element SolutionsESI
$676.9M+48.9%
Fluor logo
FluorFLR
$951M+3.6%

Other financials

Income statement

See full
Revenue$166.3M+14.3%
Operating income$41.4M-6.9%
Net income$29.6M+11.0%
EPS (diluted)$0.59+13.5%

Balance sheet

See full
Cash & equivalents$118.6M-51.6%
Total debt$81.0M+1.1%
Total equity$338.3M-23.4%
Total assets$687.4M-9.9%

Cash flow

See full
Operating cash flow-$975.0K-113%
CapEx$2.5M+39.9%
Free cash flow-$3.4M-162%

Valuation

See full
Market cap$2.78B-18.9%
Enterprise value$2.74B-16.4%
P/E25.5×-7.0×
P/S4.6×-1.5×

Profitability

See full
Operating margin19.4%-4.5pp
Net margin18.1%-0.8pp
FCF margin18.8%-5.2pp

Returns & leverage

See full
Return on equity27.9%+2.1pp
Debt / equity0.2×+0.1×
Current ratio2.4×-0.9×

Where this comes from

Reported directly by Exponent in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Exponent’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exponent's accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exponent's accounts receivable?
Exponent (EXPO) reported accounts receivable of $197.34M in Q1 2026.
How has Exponent's accounts receivable changed year-over-year?
Exponent's accounts receivable increased by 18.3% year-over-year, from $166.79M to $197.34M.
What is the long-term trend for Exponent's accounts receivable?
Over 5 years (2020 to 2025), Exponent's accounts receivable has grown at a 10.2% compound annual growth rate (CAGR), from $111.57M to $181.51M.
What does accounts receivable mean?
Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.